Eliot Finkel Investment Counsel’s Pfizer PFE Stock Holding History

Eliot Finkel Investment Counsel’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-149,135	Closed	-$4.95M	–	32
2023 Q3	$4.95M	Buy	149,135 +870	+0.6%	+$30.8K	3.32%	15
2023 Q2	$5.44M	Buy	148,265 +1,465	+1%	+$57K	3.45%	14
2023 Q1	$5.99M	Sell	146,800 -2,300	-2%	-$99.3K	3.82%	15
2022 Q4	$7.64M	Sell	149,100 -180	-0.1%	-$8.63K	4.84%	6
2022 Q3	$6.53M	Sell	149,280 -300	-0.2%	-$14.6K	4.83%	5
2022 Q2	$7.84M	Sell	149,580 -680	-0.5%	-$34.7K	5.68%	4
2022 Q1	$7.78M	Sell	150,260 -2,340	-2%	-$121K	4.59%	6
2021 Q4	$9.01M	Sell	152,600 -3,105	-2%	-$154K	5.27%	5
2021 Q3	$6.7M	Buy	155,705 +470	+0.3%	+$20.8K	4.29%	7
2021 Q2	$6.08M	Buy	155,235 +1,440	+0.9%	+$56K	3.91%	10
2021 Q1	$5.57M	Buy	153,795 +620	+0.4%	+$22K	3.59%	12
2020 Q4	$5.64M	Sell	153,175 -4,257	-3%	-$156K	4.25%	12
2020 Q3	$5.48M	Sell	157,432 -1,707	-1%	-$59.8K	4.88%	9
2020 Q2	$4.94M	Buy	159,139 +3,004	+2%	+$102K	4.89%	8
2020 Q1	$4.83M	Sell	156,135 -2,635	-2%	-$89.8K	5.27%	7
2019 Q4	$5.9M	Sell	158,770 -559	-0.4%	-$19.9K	3.82%	9
2019 Q3	$5.43M	Sell	159,329 -1,486	-0.9%	-$54K	3.88%	7
2019 Q2	$6.61M	Sell	160,815 -95	-0.1%	-$3.77K	4.24%	6
2019 Q1	$6.48M	Sell	160,910 -1,486	-0.9%	-$59.5K	4.3%	4
2018 Q4	$6.72M	Sell	162,396 -1,687	-1%	-$70K	4.92%	2
2018 Q3	$6.86M	Sell	164,083 -7,883	-5%	-$303K	4.37%	3
2018 Q2	$5.92M	Sell	171,966 -1,086	-0.6%	-$37.1K	4%	6
2018 Q1	$5.83M	Buy	173,052 +3,900	+2%	+$134K	4.1%	6
2017 Q4	$5.81M	Buy	169,152 +2,540	+2%	+$86.6K	3.83%	8
2017 Q3	$5.64M	Sell	166,612 -791	-0.5%	-$25.4K	4.03%	8
2017 Q2	$5.33M	Sell	167,403 -21	-0%	-$662	3.92%	9
2017 Q1	$5.43M	Buy	167,424 +55,820	+50%	+$1.76M	4.17%	8
2016 Q4	$3.44M	Sell	111,604 -25,928	-19%	-$792K	2.92%	19
2016 Q3	$4.42M	Buy	+137,532	New	+$4.6M	3.97%	12

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Eliot Finkel Investment Counsel's PFE Position: Q4 2023 in Review

Eliot Finkel Investment Counsel sold out of Pfizer (PFE) in Q4 2023, closing a stake of 149,135 shares — an estimated $4.95M sold.

Eliot Finkel Investment Counsel first reported a position in PFE in Q3 2016 and held it in 29 quarters. The position peaked at $9.01M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Eliot Finkel Investment Counsel reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Eliot Finkel Investment Counsel sold 149,135 Pfizer shares in Q4 2023, an estimated $4.95M.
Eliot Finkel Investment Counsel first reported a position in Pfizer in Q3 2016 and held it in 29 quarters.
Eliot Finkel Investment Counsel's Pfizer position peaked at $9.01M in Q4 2021.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Eliot Finkel Investment Counsel's 13F filing for Q4 2023, filed 18 Jan 2024.